Sanofi and GSK to seek authorization for COVID vaccine

Sanofi-GSK COVID-19 Booster More Protective Against Omicron Than Pfizer-BioNTech

Sanofi on LinkedIn: Sanofi: Press Releases, Wednesday, February 23, 2022

Here's the latest on COVID-19 vaccines

Sanofi and GSK to seek authorization for COVID vaccine

COVID vaccine from Sanofi and GSK is delayed, triggering uncertainty ahead of Europe's mass inoculation campaigns - MarketWatch

EMA starts review of Sanofi-GSK COVID vaccine application

GSK/Sanofi Covid booster delayed by lack of uninfected people to test it on, GlaxoSmithKline

Health - Axios

Health - Axios